SCHEMBL7545867

SCHEMBL7545867

Cc1ccc(N)c(C#N)c1N

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.39
POLB P06746 2/20 0.39
CD44 P16070 1/20 0.39
ALDH1A1 P00352 5/20 0.35
HSD17B10 Q99714 3/20 0.35
HPGD P15428 2/20 0.35
MAPT P10636 1/20 0.35
ALOX15 P16050 1/20 0.35
APOBEC3G Q9HC16 1/20 0.35
LMNA P02545 1/20 0.35
TDP1 Q9NUW8 3/20 0.35
TSHR P16473 2/20 0.34
CASP1 P29466 1/20 0.34
CYP3A4 P08684 1/20 0.34
GRM6 O15303 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
HTT P42858 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
CYP1A2 P05177 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8872487 0.86 POLB (0.42) KDM4EPOLBCD44ALDH1A1HSD17B10
SCHEMBL1622094 0.82 KDM4E (0.39) KDM4EPOLBALDH1A1HSD17B10HPGD
SCHEMBL24452600 0.82 KDM4E (0.39) KDM4EPOLBCD44ALDH1A1HSD17B10
SCHEMBL406265 0.78 KDM4E (0.37) KDM4EPOLBALDH1A1HSD17B10HPGD
SCHEMBL30937096 0.78 PRKACA (0.40) KDM4EPOLBALDH1A1HSD17B10HPGD
SCHEMBL6731293 0.78 CYP3A4 (0.39) KDM4EPOLBALDH1A1HSD17B10HPGD
SCHEMBL7476285 0.78 GAA (0.40) KDM4EPOLBALDH1A1HSD17B10HPGD
SCHEMBL20444046 0.76 KDM4E (0.38) KDM4EPOLBALDH1A1HSD17B10HPGD
SCHEMBL5595008 0.74 ALDH1A1 (0.39) KDM4EPOLBALDH1A1HSD17B10HPGD
SCHEMBL10991120 0.74 CYP3A4 (0.39) KDM4EPOLBALDH1A1HSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020065314-A1 COMPOSITIONS AND METHOD FOR STIMULATING HAIR GROWTH S.N. BIOTECH, INC. 2002-05-30 US disclosed
US-5767152-A USING A CYANOCARBOXYLIC ACID S.N. BIOTECH, INC. 1998-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020065314-A1 COMPOSITIONS AND METHOD FOR STIMULATING HAIR GROWTH AREG, NGF, HDGF KDM4E 4496/4885POLB 1347/4885CD44 912/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.